NASTAD Call to Action: Supervised Injection Facilities

In response to increasing incidence of hepatitis, HIV, and overdose death related to opioid and other drug use in America, the...

Jan 30, 2018 | Kim Rodgers

  • National Drug & Alcohol Facts Week 2018: Shatter the Myths about Drugs and Alcohol

    On January 22-28, the National Institute on Drug Abuse and National Institute on Alcohol Abuse will be hosting their annual National...

    Jan 15, 2018 | Andrea Grenadier

  • Commentary: The Hidden Health Crisis of the Opioid Epidemic

    Representatives from the National Viral Hepatitis Roundtable (NVHR) and Harvard Law School Center for Health Law and Policy Innovation...

    Dec 11, 2017 | Kim Rodgers

  • Watch Now: Hepatitis A 2017 Outbreak Response – Lessons from Big Cities  

    On Friday, November 3, NACCHO hosted a webinar to highlight lessons learned and updates from jurisdictions experiencing outbreaks of...

    Nov 07, 2017 | Kim Rodgers

  • Report: Science over Stigma: The Public Health Case Against HCV Treatment Sobriety...

    In response to the introduction of effective, short-course, curative hepatitis C (HCV) treatments, shifting HCV trends nationwide, and...

    Sep 14, 2017 | Kim Rodgers

  • Funding Opportunity: Projects Addressing HIV/HCV in Context of Opioid Epidemic

    amfAR, “The Foundation for AIDS Research,” is seeking grant applicants for a funding opportunity of up to $70,000. The...

    Aug 18, 2017 | Anastasia Sonneman

  • New CDC Report: Antibiotic-Resistant Foodborne Bacteria

    The Centers for Disease Control and Prevention (CDC) recently released a report on antibiotic resistance, food, and food-producing...

    Aug 15, 2017 | Amy Chang

  • NASTAD Call to Action: Urgent Response to Nation’s Hepatitis C Epidemic

    In response to the recent National Academies of Sciences, Engineering, and Medicine’s (NASEM) release of A National Strategy for the...

    Aug 01, 2017 | Kim Rodgers

  • NASTAD Call to Action: Supervised Injection Facilities

    In response to increasing incidence of hepatitis, HIV, and overdose death related to opioid and other drug use in America, the National Alliance of State and Territorial AIDS Directors (NASTAD) has evaluated evidence-based interventions intended to address these intersecting epidemics, including Supervised Injection Facilities. As part of this work, NASTAD released Call to Action: Supervised...

    Jan 30, 2018 | Kim Rodgers

    National Drug & Alcohol Facts Week 2018: Shatter the Myths about Drugs and Alcohol

    On January 22-28, the National Institute on Drug Abuse and National Institute on Alcohol Abuse will be hosting their annual National Drug & Alcohol Facts Week (NDAFW)! Taking part in National Drug & Alcohol Facts Week is a great opportunity for your local health department to reach teens and shatter the myths about drug abuse […]

    Jan 15, 2018 | Andrea Grenadier

    Commentary: The Hidden Health Crisis of the Opioid Epidemic

    Representatives from the National Viral Hepatitis Roundtable (NVHR) and Harvard Law School Center for Health Law and Policy Innovation (CHLPI) recently penned an article about the link between hepatitis C and the opioid epidemic. Per the article, the unprecedented rate of injection drug use in our country has created a new generation of hepatitis C patients […]

    Dec 11, 2017 | Kim Rodgers

    Watch Now: Hepatitis A 2017 Outbreak Response – Lessons from Big Cities  

    On Friday, November 3, NACCHO hosted a webinar to highlight lessons learned and updates from jurisdictions experiencing outbreaks of hepatitis A virus. Since November 2016, in California alone, more than 600 people have been infected with hepatitis A, 395 people have been hospitalized, and 19 have died in outbreaks related to inadequate sanitation and hygiene. […]

    Nov 07, 2017 | Kim Rodgers

    Report: Science over Stigma: The Public Health Case Against HCV Treatment Sobriety Restrictions

    In response to the introduction of effective, short-course, curative hepatitis C (HCV) treatments, shifting HCV trends nationwide, and calls for universal access to treatment, NASTAD has recently released Science over Stigma: The Public Health Case Against HCV Treatment Sobriety Restrictions,which explores the impact of private and public insurance sobriety requirements that are barriers to HCV...

    Sep 14, 2017 | Kim Rodgers

    Funding Opportunity: Projects Addressing HIV/HCV in Context of Opioid Epidemic

    amfAR, “The Foundation for AIDS Research,” is seeking grant applicants for a funding opportunity of up to $70,000. The grant is intended to support state or local level efforts addressing HIV and/or hepatitis C in the context of the opioid crisis. Eligible organizations include health departments, substance use disorder treatment providers, organizations/networks that represent people...

    Aug 18, 2017 | Anastasia Sonneman

    New CDC Report: Antibiotic-Resistant Foodborne Bacteria

    The Centers for Disease Control and Prevention (CDC) recently released a report on antibiotic resistance, food, and food-producing animals. According to the report, individuals infected by antibiotic-resistant foodborne bacteria may develop symptoms that can be more severe and harder to treat. Furthermore, findings indicate that bacteria can become resistant to antibiotics when the drugs are...

    Aug 15, 2017 | Amy Chang

    NASTAD Call to Action: Urgent Response to Nation’s Hepatitis C Epidemic

    In response to the recent National Academies of Sciences, Engineering, and Medicine’s (NASEM) release of A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report, the National Association of State and Territorial AIDS Directors (NASTAD) has issued a Call to Action and accompanying Blog Post for an urgent response to the […]

    Aug 01, 2017 | Kim Rodgers

    3 Newsletters1200 1
    Back to Top